Skip to content
lifestyle.chroniccities.us
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Sironax USA, Inc.
Sironax Announces Option Exercise and Asset Purchase
September 16, 2026
Sironax’s SARM1 Inhibitor SIR2501 Granted FDA Fast Track Designation in Chemotherapy-induced Peripheral Neuropathy (CIPN)
May 11, 2026
Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting
April 22, 2026
Sironax Appoints Clive Wang to Board of Directors
March 26, 2026
Sironax Announces Upcoming Poster Presentation on NAMPT Activation
March 20, 2026